IP Library Assignment 037116/0471
Patent Assignment
Reel/Frame 037116/0471

Security Interest

Recorded: 2015-11-23 Pages: 15
Assignor
THERAPURE BIOPHARMA INC.
Executed: 2015-11-20
Assignee
MIDCAP FINANCIAL TRUST, AS AGENT
C/O MIDCAP FINANCIAL SERVICES, LLC, AS SERVICER, 7255 WOODMONT AVE., SUITE 200, BETHESDA, MARYLAND, 20814
Covered Properties (17)
Method of Reducing a Schiff Base
Patent: 5,847,110 →
Application: 08/911,991 →
Methods for the Selective Expansion of Lymphocytes by in Vitro Cultivation
Patent: 6,194,207 →
Application: 09/016,784 →
Hemoglobin-Polysaccharide Conjugates
Patent: 6,500,930 →
Application: 09/276,686 →
Publication: US 2002/0040128
Hemoglobin-Haptoglobin Complexes
Patent: 6,479,637 →
Application: 09/302,351 →
The Efficient Culture of Stem Cells for the Production of Hemoglobin
Patent: 6,361,998 →
Application: 09/339,838 →
Modified Polysaccharides Exhibiting Altered Biological Recognition
Patent: 6,479,468 →
Application: 09/555,994 →
Methods for the Production of Tcr Gamma Delta T Cells
Patent: 6,537,812 →
Application: 09/807,987 →
Hemoglobin-Antioxidant Conjugates
Patent: 6,974,794 →
Application: 09/926,167 →
Modified Polysaccharides Exhibiting Altered Biological Recognition
Patent: 6,780,852 →
Application: 10/293,910 →
Publication: US 2003/0153531
Method of Stimulating Stem Cells
Patent: 7,524,500 →
Application: 10/471,604 →
Publication: US 2004/0151692
Process For Isolation Of Plasma Or Serum Proteins
Patent: 9,624,260 →
Application: 11/570,154 →
Publication: US 2007/0299251
Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds
Patent: 8,840,877 →
Application: 12/999,076 →
Publication: US 2011/0104114
Targeted Delivery of Antiviral Compounds Through Hemoglobin Bioconjugates
Application: 13/399,046 →
Publication: US 2012/0213732
Polysaccharide-Protein Conjugates Reversibly Coupled via Imine Bonds
Application: 14/492,443 →
Publication: US 2015/0010494
Process for Isolation of Plasma or Serum Proteins
Patent: 9,428,545 →
Application: 14/688,906 →
Publication: US 2016/0009757
Methods and Compositions for the Treatment of Histiocytosis
Application: 14/928,528 →
Publication: US 2016/0158368
Methods and Compositions For The Treatment of Erdheim-Chester Disease
Application: 62/199,529 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest May 17, 2001
From: HEMOSOL INC.
To: MANUFACTURERS LIFE INSURANCE COMPANY, THE
Reel/Frame 012333/0801 →
Security Interest Jan 16, 2002
From: HEMOSOL, INC.
To: MANUFACTURERS LIFE INSURANCE COMPANY, THE
Reel/Frame 012513/0043 →
Assignment of Assignor's Interest Jan 25, 2005
From: MUELLER, SUSAN; BELL, DAVID; MATTHEWS, KATHRYN EMMA
To: HEMOSOL LP
Reel/Frame 015619/0362 →
Assignment of Assignor's Interest Jul 13, 2007
From: LIHME, ALLAN OTTO FOG
To: UPFRONT CHROMATOGRAPHY A/S
Reel/Frame 019598/0284 →
Change of Name Feb 27, 2008
From: 2140304 ONTARIO INC.
To: HEMOSOL BIOPHARMA INC.
Reel/Frame 020566/0895 →
Assignment of Assignor's Interest Feb 27, 2008
From: HEMOSOL LP
To: 2140304 ONTARIO INC.
Reel/Frame 020566/0874 →
Assignment of Assignor's Interest Feb 27, 2008
From: HEMOSOL INC.
To: HEMOSOL LP
Reel/Frame 020566/0833 →
Assignment of Assignor's Interest Nov 20, 2008
From: HEDLUND, BO L.; WEBER, THOMAS P.; DRAGSTEN, PAUL R.; HANSON, GREGORY J.
To: BIOMEDICAL FRONTIERS INCORPORATED
Reel/Frame 021861/0289 →
Security Agreement Nov 25, 2008
From: BIOMEDICAL FRONTIERS INCORPORATED
To: THERAPURE BIOPHARMA INC.
Reel/Frame 021890/0102 →
Change of Name Dec 30, 2008
From: HEMOSOL BIOPHARMA INC.
To: THERAPURE BIOPHARMA INC.
Reel/Frame 022034/0596 →
Assignment of Assignor's Interest Dec 30, 2008
From: HEMOSOL INC.
To: HEMOSOL LP
Reel/Frame 022034/0401 →
Vesting Order Dec 30, 2008
From: HEMOSOL LP
To: 2140304 ONTARIO INC.
Reel/Frame 022034/0536 →
Change of Name Dec 30, 2008
From: 2140304 ONTARIO INC.
To: HEMOSOL BIOPHARMA INC.
Reel/Frame 022034/0592 →
Assignment of Assignor's Interest Nov 18, 2011
From: BIOMEDICAL FRONTIERS, INCORPORATED
To: THERAPURE BIOPHARMA INC.
Reel/Frame 027254/0754 →
Assignment of Assignor's Interest Jun 18, 2012
From: ADAMSON, GORD; BELL, DAVID; BROOKES, STEVEN
To: THERAPURE BIOPHARMA INC.
Reel/Frame 028394/0946 →
Assignment of Assignor's Interest Jul 8, 2013
From: UPFRONT CHROMATOGRAPHY A/S
To: THERAPURE BIOPHARMA INC.
Reel/Frame 030752/0746 →
Release of Security Interest Nov 16, 2015
From: THE MANUFACTURERS LIFE INSURANCE COMPANY
To: HEMOSOL INC.
Reel/Frame 037048/0599 →
Assignment of Assignor's Interest Dec 14, 2015
From: BIOMEDICAL FRONTIERS, INCORPORATED
To: THERAPURE BIOPHARMA INC.
Reel/Frame 037281/0151 →
Assignment of Assignor's Interest Jan 18, 2016
From: EBERLE-AYRES, IRINA; CUTLER, MURRAY J.; MATTHEWS, KATHRYN; BROOKES, STEVEN
To: THERAPURE BIOPHARMA INC.
Reel/Frame 037510/0001 →
Assignment of Security Interest Feb 5, 2016
From: MDS INC.
To: CATALYST FUND LIMITED PARTNERSHIP II
Reel/Frame 037732/0097 →
Assignment of Security Interest Feb 5, 2016
From: THE BANK OF NOVA SCOTIA
To: MDS INC.
Reel/Frame 037731/0875 →
Release of Security Interest Feb 16, 2016
From: CATALYST FUND LIMITED PARTNERSHIP II
To: THERAPURE BIOPHARMA INC.
Reel/Frame 037743/0038 →
Confirmatory Intellectual Property Assignment Oct 23, 2019
From: THERAPURE BIOPHARMA, INC.
To: EVOLVE BIOLOGICS INC.
Reel/Frame 050798/0522 →
Release of Security Interest Oct 21, 2020
From: MIDCAP FINANCIAL TRUST
To: THERAPURE BIOPHARMA INC.
Reel/Frame 054123/0837 →
Security Interest May 31, 2023
From: EVOLVE BIOLOGICS INC.; TBI PHARMA HOLDINGS LTD.
To: MONROE CAPITAL MANAGEMENT ADVISORS, LLC
Reel/Frame 063817/0151 →